Cargando…
Identification of New N-methyl-piperazine Chalcones as Dual MAO-B/AChE Inhibitors
Monoamine oxidase-B (MAO-B), acetylcholinesterase (AChE), and butyrylcholinesterase (BChE) have been considered target enzymes of depression and neurodegenerative diseases, including Alzheimer’s disease (AD). In this study, seventeen N-methyl-piperazine chalcones were synthesized, and their inhibito...
Autores principales: | El-Damasy, Ashraf K., Park, Jong Eun, Kim, Hyun Ji, Lee, Jinhyuk, Bang, Eun-Kyoung, Kim, Hoon, Keum, Gyochang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860728/ https://www.ncbi.nlm.nih.gov/pubmed/36678580 http://dx.doi.org/10.3390/ph16010083 |
Ejemplares similares
-
Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders
por: Mathew, Bijo, et al.
Publicado: (2021) -
Discovery of 3-((3-amino-1H-indazol-4-yl)ethynyl)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide (AKE-72), a potent Pan-BCR-ABL inhibitor including the T315I gatekeeper resistant mutant
por: El-Damasy, Ashraf K., et al.
Publicado: (2023) -
Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders
por: Koyiparambath, Vishal Payyalot, et al.
Publicado: (2021) -
Discovery of new 6-ureido/amidocoumarins as highly potent and selective inhibitors for the tumour-relevant carbonic anhydrases IX and XII
por: El-Damasy, Ashraf K., et al.
Publicado: (2023) -
Discovery of New Quinolone-Based Diarylamides as Potent B-RAF(V600E)/C-RAF Kinase Inhibitors Endowed with Promising In Vitro Anticancer Activity
por: Kim, Hyun Ji, et al.
Publicado: (2023)